Radix Polygalae Extract for Diverse Health Applications

Publication ID: 24-11857592_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Radix Polygalae Extract for Diverse Health Applications,” Published Technical Disclosure No. 24-11857592_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857592_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,592.

Summary of the Inventive Concept

This inventive concept leverages the core technology of the original patent to expand Radix Polygalae extract's therapeutic potential into novel health applications, addressing unmet needs in traumatic brain injury, post-traumatic stress disorder, sleep disorders, athletic performance, and chronic stress.

Background and Problem Solved

The original patent focused on treating attention-deficit hyperactivity disorder (ADHD) using Radix Polygalae extract. However, this limited the extract's potential to other health areas. The new inventive concept addresses this limitation by exploring the extract's applicability to diverse health applications, where its neuroprotective, anxiolytic, and cognitive-enhancing properties can provide significant benefits.

Detailed Description of the Inventive Concept

The new inventive concept comprises a range of novel applications and use cases for Radix Polygalae extract. These include: (1) a system for improving cognitive function in individuals with traumatic brain injury by combining the extract with a neuroprotective agent; (2) a method for reducing anxiety in individuals with post-traumatic stress disorder by administering a pharmaceutical composition comprising the extract and a serotonin reuptake inhibitor; (3) a composition for treating sleep disorders by combining the extract with melatonin; (4) a method for enhancing athletic performance by administering a nutritional supplement comprising the extract and branched-chain amino acids; and (5) a system for reducing stress in individuals with chronic stress using a transdermal patch comprising the extract and a cortisol-lowering agent. These novel applications harness the extract's therapeutic potential to address significant unmet needs in various health areas.

Novelty and Inventive Step

The new inventive concept introduces novel combinations, formulations, and routes of administration for Radix Polygalae extract, expanding its therapeutic scope beyond ADHD. The inventive step lies in recognizing the extract's potential in diverse health applications and developing specific formulations and methods to address these unmet needs.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include varying the ratio of Radix Polygalae extract to other ingredients, using different neuroprotective agents or serotonin reuptake inhibitors, or exploring other routes of administration, such as injectables or topical creams. Variations could also involve combining the extract with other natural compounds or pharmaceuticals to enhance its therapeutic effects.

Potential Commercial Applications and Market

The new inventive concept has significant commercial potential in various health industries, including pharmaceuticals, nutraceuticals, and medical devices. Target markets include traumatic brain injury, post-traumatic stress disorder, sleep disorders, athletic performance, and chronic stress, with potential applications in military, sports, and wellness sectors.

CPC Classifications

SectionClassGroup
A A61 A61K36/69
A A61 A61K9/0053
A A61 A61K9/485
A A61 A61K9/4825
A A61 A61K9/4858
A A61 A61K47/02
A A61 A61K47/12
A A61 A61P25/28
A A61 A61K2236/333

Original Patent Information

Patent NumberUS 11,857,592
TitlePolygala extract for the treatment of attention-deficit hyperactivity disorder
Assignee(s)BioLite Inc.